Insulet Corp (PODD)

$332.13 -8.16 (-2.40%)
Market Cap 24.06B
Revenue (ttm) 2.07B
Net Income (ttm) 418.30M
EPS (ttm) N/A
PE Ratio 79.70
Forward PE 72.93
Profit Margin 20.19%
Debt to Equity Ratio 0.96
Volume 812,000
Avg Vol 603,168
Day's Range N/A - N/A
Shares Out 70.39M
Stochastic %K 44%
Beta 1.36
Analysts Strong Sell
Price Target $357.05

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 600 7000
Address:
100 Nagog Park, Acton, United States
IN0V8
IN0V8 Sep. 16 at 8:14 PM
$PODD Piper Sandler raises target price to $360 from $320
0 · Reply
highnihilism
highnihilism Sep. 16 at 5:15 PM
XLV: Health Care Select → $COR Cencora $DVA Davita $ZBH Zimmer Biomet $A Agilent Technologies $PODD Insulet
0 · Reply
highnihilism
highnihilism Sep. 16 at 4:29 PM
S&P 500 → $CTRA Coterra Energy $APD Air Products & Chemicals $PODD Insulet $XYL Xylem $HAS Hasbro
0 · Reply
BillionerOfKing
BillionerOfKing Sep. 16 at 2:37 PM
$PODD Current Stock Price: $344.69 Contracts to trade: $340 PODD Sep 19 2025 Call Entry: $5.20 Exit: $8.86 ROI: 70% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DonCorleone77
DonCorleone77 Sep. 16 at 11:16 AM
$PODD -- Insulet CFO Ana Maria Chadwick to leave role, Flavia Pease to succeed -- Insulet expects to exceed Q3 revenue view of up 22%-25%
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 13 at 10:42 AM
Enter: $PODD OCT 17 2025 $350 CALLS Buy in Price: $6.63 - $10.80 Take Profit: $7.49 Stop Bleeding: $5.83 ROI Potential: 13% Exit Within: 39 Minutes https://moneygroup.us/alerts
0 · Reply
IN0V8
IN0V8 Sep. 12 at 3:33 PM
$PODD Opportunity JP Morgan raises target price to $415 from $340
0 · Reply
Mating_Panda
Mating_Panda Sep. 12 at 2:19 PM
Diabetes Pump Market Caps: $TNDM: $848 Million $PODD: $24 Billion $BBNX: 1.1 Billion $MODD: $46 million I know we're pre revenue but I think $MODD can afford to gap up over $1.
2 · Reply
jheerdink
jheerdink Sep. 12 at 6:27 AM
$MODD Modular Medical Accelerates Campaign Targeting $3 Billion Adult Market with User-Friendly Pivot Insulin Pump – ( $PODD $MDT $TNDM ) https://vistapglobal.com/modular-medical-accelerates-campaign-targeting-3-billion-adult-market-with-user-friendly-pivot-insulin-pump-modd/
0 · Reply
jheerdink
jheerdink Sep. 11 at 9:09 PM
$MODD Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target the estimated $3 billion dollar adult "almost-pumpers" market with its user-friendly and affordable design, today announced the successful completion of a clinical study with the MODD1 pump. $PODD https://finance.yahoo.com/news/modular-medical-announces-completion-clinical-200500291.html
0 · Reply
Latest News on PODD
Medical device maker Insulet names industry veteran Flavia Pease as CFO

Sep 16, 2025, 7:25 AM EDT - 12 hours ago

Medical device maker Insulet names industry veteran Flavia Pease as CFO

Insulet Announces CFO Transition

Sep 16, 2025, 7:00 AM EDT - 12 hours ago

Insulet Announces CFO Transition

Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 9, 2025, 2:31 PM EDT - 7 days ago

Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript

Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 4, 2025, 6:33 PM EDT - 12 days ago

Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Insulet Elevates Eric Benjamin to Chief Operating Officer

Aug 25, 2025, 5:00 PM EDT - 22 days ago

Insulet Elevates Eric Benjamin to Chief Operating Officer

Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV

Aug 19, 2025, 1:20 PM EDT - 4 weeks ago

Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV

CSCO RKT IGV

Insulet to Participate in Upcoming Investor Conferences

Aug 19, 2025, 6:00 AM EDT - 4 weeks ago

Insulet to Participate in Upcoming Investor Conferences

20 stocks in the S&P 500 that are high achievers this earnings season

Aug 15, 2025, 8:52 AM EDT - 4 weeks ago

20 stocks in the S&P 500 that are high achievers this earnings season

ANET APH COIN CTRA EQT EXE FICO

Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold

Aug 13, 2025, 11:49 PM EDT - 4 weeks ago

Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

Aug 7, 2025, 1:08 PM EDT - 5 weeks ago

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 11:14 AM EDT - 5 weeks ago

Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript

Insulet beats second-quarter profit estimates on strong demand for insulin pumps

Aug 7, 2025, 8:39 AM EDT - 5 weeks ago

Insulet beats second-quarter profit estimates on strong demand for insulin pumps

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

Aug 7, 2025, 7:00 AM EDT - 5 weeks ago

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

Jul 31, 2025, 9:52 AM EDT - 6 weeks ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM EW ISRG LLY SYK

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

Jul 21, 2025, 10:27 AM EDT - 2 months ago

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

CMG COF DXCM FSLR INTU LLY MA

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

Jul 8, 2025, 6:00 AM EDT - 2 months ago

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Jun 19, 2025, 6:00 AM EDT - 3 months ago

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

20 stocks bucking bad trends on Wall Street — what might be next for them?

Jun 10, 2025, 10:53 AM EDT - 3 months ago

20 stocks bucking bad trends on Wall Street — what might be next for them?

AMT ANET AVGO BSX TRMB BAC C

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

Jun 10, 2025, 8:30 AM EDT - 3 months ago

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

20 stocks of companies that have improved profit margins and are expected to grow quickly

Jun 9, 2025, 9:28 AM EDT - 3 months ago

20 stocks of companies that have improved profit margins and are expected to grow quickly

AMD AVGO CSGP DASH ENPH FICO FTNT

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 23, 2025, 6:01 AM EDT - 4 months ago

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Outlier Money Flows Lift Insulet

May 14, 2025, 7:20 AM EDT - 4 months ago

Outlier Money Flows Lift Insulet

Insulet Announces Publication of 2024 Sustainability Report

May 13, 2025, 6:00 AM EDT - 4 months ago

Insulet Announces Publication of 2024 Sustainability Report

20 stocks of companies showing excellent earnings-season trends even as the economy cools

May 12, 2025, 11:18 AM EDT - 4 months ago

20 stocks of companies showing excellent earnings-season trends even as the economy cools

AMD APH CF CTRA DVN ENPH EQT

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

May 9, 2025, 6:31 PM EDT - 4 months ago

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

May 9, 2025, 12:31 PM EDT - 4 months ago

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

MNST TSLA

Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad

May 9, 2025, 11:05 AM EDT - 4 months ago

Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad

Insulet Is the Top S&P 500 Performer Today. Here's Why.

May 9, 2025, 10:11 AM EDT - 4 months ago

Insulet Is the Top S&P 500 Performer Today. Here's Why.

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:35 PM EDT - 4 months ago

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

Insulet beats quarterly profit estimates on insulin pump demand

May 8, 2025, 4:28 PM EDT - 4 months ago

Insulet beats quarterly profit estimates on insulin pump demand

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)

May 8, 2025, 4:01 PM EDT - 4 months ago

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)

Insulet Names New CEO, Expects to Top Revenue Projections

Apr 28, 2025, 10:26 AM EDT - 5 months ago

Insulet Names New CEO, Expects to Top Revenue Projections

Insulet Appoints Ashley McEvoy President and CEO

Apr 28, 2025, 6:00 AM EDT - 5 months ago

Insulet Appoints Ashley McEvoy President and CEO

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Apr 3, 2025, 6:00 AM EDT - 5 months ago

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Mar 19, 2025, 4:01 PM EDT - 6 months ago

Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Insulet Announces Pricing of Senior Notes Due 2033

Mar 18, 2025, 4:32 PM EDT - 6 months ago

Insulet Announces Pricing of Senior Notes Due 2033

Insulet Announces Proposed Financing Transactions

Mar 18, 2025, 7:35 AM EDT - 6 months ago

Insulet Announces Proposed Financing Transactions

Insulet Leans Bullish (Technical Analysis)

Mar 17, 2025, 11:53 PM EDT - 6 months ago

Insulet Leans Bullish (Technical Analysis)

Insulet to Host Investor Day on June 5, 2025

Mar 11, 2025, 6:00 AM EDT - 6 months ago

Insulet to Host Investor Day on June 5, 2025

Insulet Sales Keep Rising

Feb 26, 2025, 8:04 AM EST - 7 months ago

Insulet Sales Keep Rising

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst

Feb 21, 2025, 1:28 PM EST - 7 months ago

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst

Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 11:37 PM EST - 7 months ago

Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript

Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year

Feb 20, 2025, 4:01 PM EST - 7 months ago

Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

Jan 13, 2025, 4:01 PM EST - 8 months ago

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Jan 10, 2025, 6:00 AM EST - 8 months ago

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Heavy Interest in Insulet's Insulin Delivery Device

Dec 27, 2024, 3:47 PM EST - 9 months ago

Heavy Interest in Insulet's Insulin Delivery Device

Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case

Dec 5, 2024, 11:05 AM EST - 10 months ago

Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case

Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court

Dec 4, 2024, 4:28 PM EST - 10 months ago

Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court

Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines

Nov 20, 2024, 6:26 PM EST - 10 months ago

Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S.

Nov 20, 2024, 8:30 AM EST - 10 months ago

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S.

IN0V8
IN0V8 Sep. 16 at 8:14 PM
$PODD Piper Sandler raises target price to $360 from $320
0 · Reply
highnihilism
highnihilism Sep. 16 at 5:15 PM
XLV: Health Care Select → $COR Cencora $DVA Davita $ZBH Zimmer Biomet $A Agilent Technologies $PODD Insulet
0 · Reply
highnihilism
highnihilism Sep. 16 at 4:29 PM
S&P 500 → $CTRA Coterra Energy $APD Air Products & Chemicals $PODD Insulet $XYL Xylem $HAS Hasbro
0 · Reply
BillionerOfKing
BillionerOfKing Sep. 16 at 2:37 PM
$PODD Current Stock Price: $344.69 Contracts to trade: $340 PODD Sep 19 2025 Call Entry: $5.20 Exit: $8.86 ROI: 70% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DonCorleone77
DonCorleone77 Sep. 16 at 11:16 AM
$PODD -- Insulet CFO Ana Maria Chadwick to leave role, Flavia Pease to succeed -- Insulet expects to exceed Q3 revenue view of up 22%-25%
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 13 at 10:42 AM
Enter: $PODD OCT 17 2025 $350 CALLS Buy in Price: $6.63 - $10.80 Take Profit: $7.49 Stop Bleeding: $5.83 ROI Potential: 13% Exit Within: 39 Minutes https://moneygroup.us/alerts
0 · Reply
IN0V8
IN0V8 Sep. 12 at 3:33 PM
$PODD Opportunity JP Morgan raises target price to $415 from $340
0 · Reply
Mating_Panda
Mating_Panda Sep. 12 at 2:19 PM
Diabetes Pump Market Caps: $TNDM: $848 Million $PODD: $24 Billion $BBNX: 1.1 Billion $MODD: $46 million I know we're pre revenue but I think $MODD can afford to gap up over $1.
2 · Reply
jheerdink
jheerdink Sep. 12 at 6:27 AM
$MODD Modular Medical Accelerates Campaign Targeting $3 Billion Adult Market with User-Friendly Pivot Insulin Pump – ( $PODD $MDT $TNDM ) https://vistapglobal.com/modular-medical-accelerates-campaign-targeting-3-billion-adult-market-with-user-friendly-pivot-insulin-pump-modd/
0 · Reply
jheerdink
jheerdink Sep. 11 at 9:09 PM
$MODD Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target the estimated $3 billion dollar adult "almost-pumpers" market with its user-friendly and affordable design, today announced the successful completion of a clinical study with the MODD1 pump. $PODD https://finance.yahoo.com/news/modular-medical-announces-completion-clinical-200500291.html
0 · Reply
Grouphome
Grouphome Sep. 10 at 4:12 PM
$PODD new long. Some of these long term set ups are indicating we’re just starting.
0 · Reply
Bullish_Team
Bullish_Team Sep. 10 at 1:49 PM
$PODD it iss
0 · Reply
AMUNRATHEBLACKGOD
AMUNRATHEBLACKGOD Sep. 10 at 10:45 AM
$BBNX $HIMS $CRMD $PODD BBNX 75-80.00 IMHO
0 · Reply
JarvisFlow
JarvisFlow Sep. 8 at 2:37 PM
Oppenheimer has adjusted their stance on Insulet ( $PODD ), setting the rating to Outperform with a target price of 324 → 365.
0 · Reply
StockAutoPro
StockAutoPro Sep. 8 at 1:47 AM
$PODD: Buy target $346.43 Sell target $365.85 Expect significant growth due to increased demand for advanced diabetes management products.
0 · Reply
Bullish_Team
Bullish_Team Sep. 7 at 9:46 PM
$PODD will retest $335 this week
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Sep. 7 at 10:55 AM
$PODD beauty
1 · Reply
healthcareguru
healthcareguru Sep. 5 at 4:33 PM
$BBNX sounded horrible at the Wells presentation…couldn’t stop talking about massive competitive threat from $PODD. Both clearly insanely overvalued. 👎 $XLV $XBI $IWM
1 · Reply
scientificway
scientificway Sep. 3 at 8:38 PM
$PODD buy and hold. PMN, strong support. Should be 0.5-11 today is the chance
0 · Reply
StockAutoPro
StockAutoPro Sep. 3 at 5:32 AM
$PODD: Buy target $342.92 Sell target $362.17 Strong growth potential in diabetes management sector due to increasing global prevalence and technology advancements.
0 · Reply
StockAutoPro
StockAutoPro Aug. 31 at 6:39 AM
$PODD: Buy target $337.88 Sell target $356.87 Rising demand for diabetes management products boosts growth potential for this innovative medical device company.
0 · Reply
jheerdink
jheerdink Aug. 26 at 11:25 PM
$MODD Production Milestone Further Positions Modular Medical for U.S. and EU Growth https://vistapglobal.com/production-milestone-further-positions-modular-medical-for-u-s-and-eu-growth-modd-lly-mdt-podd/ $LLY $PODD
0 · Reply